Works matching IS 02724391 AND DT 2024 AND VI 85 AND IP 8


Results: 14
    1
    2
    3
    4
    5
    6

    Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway.

    Published in:
    Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70028
    By:
    • Islam, Md. Tahajul;
    • Malik, Abdul;
    • Alshememry, Abdullah K.;
    • Chowdhury, Raihan;
    • Bhuia, Md. Shimul;
    • Fatima, Sabiha;
    • Hossen, Md. Samim;
    • Rakib, Asraful Islam;
    • Mollah, Faysal;
    • Akbor, Md. Showkoth;
    • Bappi, Mehedi Hasan;
    • Saim, Md. Abu;
    • Islam, Muhammad Torequl
    Publication type:
    Article
    7
    8
    9
    10
    11

    Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.

    Published in:
    Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70022
    By:
    • Yang, Jin;
    • Zhang, Yan;
    • Li, Yue‐Chu;
    • Wang, Qing‐Xin;
    • Zhang, Meng‐Yuan;
    • Xu, Yu‐Jing;
    • Wang, Jing‐Jing;
    • Liang, Xiao‐Ting;
    • Jing, Xiao‐Long;
    • Zhou, Shuang‐Shuang;
    • Li, Qing‐Qing;
    • Wang, Zi‐Xuan;
    • Zhou, Yun;
    • Qiao, Nuo;
    • Wei, Tian‐Hua;
    • Ding, Ning;
    • Xue, Xin;
    • Yu, Yan‐Cheng;
    • Wang, Xiao‐Long;
    • Sun, Shan‐Liang
    Publication type:
    Article
    12
    13

    Issue Information.

    Published in:
    Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70024
    Publication type:
    Article
    14